HIV-1 subtypes and latent reservoirs

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Latent Human Immunodeficiency Virus type 1 (HIV-1) reservoirs present a major barrier to a functional cure.
• HIV-1 subtype-specific variations, particularly in transcription factor binding sites (TFBS) within the long terminal repeat (LTR), may influence viral latency and the size of these reservoirs.
• Understanding the regulatory mechanisms controlling HIV-1 transcription (ON/OFF states) is critical for therapeutic development.

Approach:

• Reviewing current research on HIV-1 subtype-specific variations and their role in HIV-1 latency.
• Examining the molecular components involved in HIV-1 transcriptional regulation, including the LTR and Tat protein.
• Assessing the development and application of subtype-specific assays for quantifying latent viral reservoirs.

Key Points:

• Subtype-specific TFBS variations are linked to differential impacts on HIV-1 latency.
• HIV-1 subtype B infections are associated with larger latent reservoirs, requiring further validation.
• Emerging HIV-1 subtype C strains with LTR variants show enhanced latency reversal.

Conclusions:

• Latent HIV-1 remains a significant obstacle to achieving a functional cure.
• Further research is essential to elucidate the ON/OFF decision-making process of HIV-1 latency.
• Developing accurate assays and potent latency-reversing agents targeting diverse viral subtypes is crucial for advancing HIV-1 cure strategies.